Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rate vs Rhythm Control for Postoperative Atrial Fibrillation
NCT02132767Phase 3Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- May 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of amiodarone in Atrial fibrillation (AFib) and atrial flutter (AFL) (2 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Total Number of Days in Hospital at 60 days. Started May 2014; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT02132767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132767.